{
    "organizations": [],
    "uuid": "c473ededf1c0c97b880425e807c3a5f1758b3fe9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glaxosmithkline-receives-european/brief-glaxosmithkline-receives-european-approval-for-expanded-indication-for-fluarix-tetra-for-ages-six-months-and-older-idUSFWN1Q50PY",
    "ord_in_thread": 0,
    "title": "BRIEF-Glaxosmithkline ‍Receives European Approval For Expanded Indication For Fluarix Tetra For Ages Six Months And Older​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Glaxosmithkline Plc:\n* ‍RECEIVES EUROPEAN APPROVAL FOR EXPANDED INDICATION FOR FLUARIX TETRA (INFLUENZA VACCINE) FOR AGES SIX MONTHS AND OLDER​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ",
    "published": "2018-02-15T19:08:00.000+02:00",
    "crawled": "2018-02-16T17:06:21.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "glaxosmithkline",
        "plc",
        "european",
        "approval",
        "expanded",
        "indication",
        "fluarix",
        "tetra",
        "influenza",
        "vaccine",
        "age",
        "six",
        "month",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}